Global Advisory Issued to Metals, Plastics, Hardware Manufacturers, Suppliers & Distributors After Accreditation Oversight Irregularity

Rezul News/10731573
WORLDWIDE INDUSTRIES 2018-2026 FRAUD
A Worldwide Advisory Has Been Issued After The Discovery Of The Guberman Anomaly-Discovery — A Federal Contract Irregularity Showing ANAB Listed As An "Underwriter," A Role It Does Not hold. If The System That Approves Materials Is Built On False Information, Trust In Those Approvals Is Weakened, And No Waiver Can Undo The Conditions Under Which Materials Were Originally Approved.

STRATFORD, Conn. - Rezul -- Daryl Guberman — a 40‑year Quality‑Systems Expert, Boeing Shareholder & CEO of GUBERMAN‑PMC LLC, and long‑time industry advocate — has issued a global advisory to metals manufacturers, plastics processors, hardware producers, distributors, and supply‑chain organizations following the discovery of a significant irregularity involving the American National Accreditation Board (ANAB) and U.S. Department of State Work Order 19AQMM18R0131.

In that federal document, ANAB is listed as an "underwriter" — a role that does not exist within ANAB's publicly defined functions or within any recognized accreditation framework. This discrepancy, known internationally as the Guberman Anomaly-Discovery, raises questions about the integrity of the accreditation environment between 2018 and the present. https://guberman-quality.com/wp-content/uploads/2026/03/GUBERMAN-ANOMALY-FEBRUARY-2026.docx.pdf

Important Advisory to All Industries Worldwide


More on Rezul News
This advisory highlights that products, materials, and components manufactured between 2018 and the present were produced inside an oversight environment now documented to contain a fraudulent irregularity — the ANAB underwriter representation revealed in the GUBERMAN Anomaly Discovery. With each passing day, additional products continue to be manufactured under the same compromised accreditation conditions across industries worldwide. Until this oversight failure is addressed, the global system responsible for approving new items remains affected, a reality that requires immediate, proactive review from every manufacturer, supplier, end‑user, and citizen who relies on the integrity of that worldwide oversight chain.

However:

Oversight‑Affects‑Products


Because ANAB identified itself as an underwriter in a federal contract 19AQMM18R0131, on a private website, and in a technical publication (pages 4-5 /GUBERMAN Anomaly Discovery)-An, the oversight environment directly affects products manufactured between 2018 and the present. Products made under those conditions fall within ANAB's claimed responsibility.

Products made in an environment where the accreditation chain contains false information are affected by that environment, even if they are dimensionally correct.

A waiver from the FDA or FAA cannot undo fraudulent oversight conditions or retroactively validate approvals issued under a compromised accreditation environment.

Oversight System, and Product Issues

More on Rezul News
Between 2018-2026, companies worldwide may have operated under accreditation conditions that are now in question, including:
  • ISO 9001, ISO 13485, AS9100, and other certifications issued under ANAB‑accredited registrars
  • Supply‑chain approvals dependent on those certifications
  • Quality‑system validations tied to ANAB's oversight
The issue is systemic — tied to the environment of oversight, not the performance of individual products.

EXAMPLE OF FAILURES:

Expanded Structural Findings, Regulatory Limits, and Global Impact

Structural Collapse: PRI, NADCAP, MedAccred, ANAB
  • MedAccred sits under PRI
  • PRI sits under ANAB
  • ANAB is tied to a false representation in a federal contract
When the top of the chain is compromised, everything below it becomes contaminated.

Integrated Oversight‑Affects‑Products Language

Products manufactured between 2018 and the present are affected because the oversight system validating them was compromised. ANAB's self‑identification as an underwriter places responsibility on them for the conditions under which those products were approved.

Regulatory Limits
  • FAA and FDA cannot waive structural fraud
  • False or misleading records invalidate approvals
  • Structural fraud cannot be excused
Global Impact
  • Mutual recognition structures spread contamination
  • Rebranding (AI9100, GLOBAC) does not erase historical oversight conditions
  • Cosmetic changes cannot rewrite the past
"The world is rarely healed by institutions. It is healed by the one individual who sees the wound clearly enough — and cares deeply enough — to close it."
I have seen the wound.
I have mapped the fracture.
I am offering the repair.


Media Contact
DARYL GUBERMAN
***@yahoo.com
203 556 1493


Source: GUBERMAN-PMC,LLC

Show All News | Disclaimer | Report Violation

0 Comments

Latest on Rezul News